Boothbay Fund Management’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-26,500
Closed -$920K 2024
2023
Q3
$920K Sell
26,500
-49,300
-65% -$1.7M 0.02% 806
2023
Q2
$2.49M Buy
+75,800
New +$2.61M 0.05% 471

Other funds holding VTYX

Boothbay Fund Management's VTYX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 251,994 shares — an estimated $2.28M sold.

Boothbay Fund Management first reported a position in VTYX in Q1 2023 and held it in 9 quarters. The position peaked at $2.28M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 251,994 Ventyx Biosciences shares in Q1 2026, an estimated $2.28M.
  • Boothbay Fund Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 9 quarters.
  • Boothbay Fund Management's Ventyx Biosciences position peaked at $2.28M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.